Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011
Rapid Disease Course in African Americans With Multiple Sclerosis
Neurol 75:217-223, Kister,I., et al, 2010
Diagnosis and Management of Active Intracranial Atherosclerotic Disease
Stroke 49:e221-e223, Narwal, P.,et al, 2018
Intracranial Atherosclerosis
Lancet 383:984-998, Qureshi, A. & Caplan, L.R., 2014
Alcohol Use and Risk of Intracerebral Hemorrhage
Neurol 88:2043-2051, Chen, C.J.,et al, 2017
Infliximab for the Treatment of CNS Sarcoidosis
Neurol 89:2092-2100, Gelfand, J.M.,et al, 2017
Acute Infection Contributes to Racial Disparities in Stroke Mortality
Neurol 82:914-921, Levine, D.A.,et al, 2014
Sickle Cell Trait and Incident Ischemic Stroke in the Atherosclerosis Risk in Communities Study
Stroke 45:2863-2867, Caughey, M.C.,et al, 2014
Increased Tissue Damage and Lesion Volumes in African Americans with Multiple Sclerosis
Neurol 74:538-544,532, Weinstock-Guttman,B.,et al, 2010
Acute Headache Diagnosis in Pregnant Women
Neurol 85:1024-1030, Robbins, M.S.,et al, 2015
Cysticerosis
eMedicine Feb 26, Mansur,M.M.,et al, 2010
Intracerebral Haemorrhage
Lancet 373:1632-1644, Qureshi,A.I.,et al, 2009
Racial Differences in Idiopathic Intracranial Hypertension
Neurol 70:861-867, Bruce,B.B.,et al, 2008
Racial Differences in Microbleed Prevalence in Primary Intracerebral Hemorrhage
Neurol 71:1176-1182, Copenhaver,B.R.,et al, 2008